A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
מצבים רפואיים
LGLL - Large Granular Lymphocytic Leukemia · Primary Cutaneous Gamma-Delta T-Cell Lymphoma · Primary Cutaneous CD8+ Aggressive Epidermotropic T-Cell Lymphoma · Hepatosplenic T-cell Lymphoma · Subcutaneous Panniculitis-Like T-Cell Lymphoma · Aggressive NK Cell Leukemia · Systemic EBV1 T-cell Lymphoma, if CD8 Positive · Hydroa Vacciniforme-Like Lymphoproliferative Disorder · Extranodal NK/T Cell Lymphoma, Nasal Type · Enteropathy-Associated T-Cell Lymphoma · Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma · Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker) · Cutaneous PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker)
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Dren Investigational Site, Birmingham, Alabama, United States
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-735-5277Dren Investigational Site, Duarte, California, United States
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Irvine, California, United States
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Redwood City, California, United States
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-735-5277Dren Investigational Site, New Haven, Connecticut, United States
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Tampa, Florida, United States
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Boston, Massachusetts, United States
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-735-5277Dren Investigational Site 1, New York, New York, United States
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-735-5277Dren Investigational Site 2, New York, New York, United States
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Columbus, Ohio, United States
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-735-5277Dren Investigational Site 2, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Houston, Texas, United States
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Charlottesville, Virginia, United States
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-735-5277Dren Investigational Site, Fairfax, Virginia, United States
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Seattle, Washington, United States
Contact: Study coordinator (Dren Cntral Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Clayton, Victoria, Australia
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Richmond, Victoria, Australia
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-735-5277Dren Investigational Site, Nedlands, Washington, Australia
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-735-5277Dren Investigational Site, Pierre-Bénite, France
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Rennes, France
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Toulouse, France
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Berlin, Germany
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Cologne, Germany
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Leipzig, Germany
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site 1, Hong Kong, Hong Kong, Hong Kong
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site 2, Hong Kong, Hong Kong
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Bologna, Italy
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site 1, Busan, South Korea
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site 2, Busan, South Korea
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Goyang-si, South Korea
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site 1, Seoul, South Korea
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site 2, Seoul, South Korea
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site 3, Seoul, South Korea
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Barcelona, Spain
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Salamanca, Spain
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Tainan, Taiwan
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277Dren Investigational Site, Taipei, Taiwan
Contact: Study coordinator (Dren Central Contact) · DR-01-ONC-001_inquiries@drenbio.com · 415-737-5277
מובילי המחקר
Wan-Jen Hong, MD
Study Director
Dren Bio